A Food and Drug Administration (FDA) advisory group recommended the approval of a novel blood test for colon cancer on Thursday. The panel ruled 7-2 to approve Guardant Health's Shield test, citing its advantages above its risks.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045